Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing
1272
Opposition/ Response by Amgen Inc. to #1260 Brief Roche's Bench Memorandum to Preclude Amgen from Introducing Testimony Related to Pegylation of Non-EPO Compounds. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5)(Gottfried, Michael)
<![CDATA[
Case 1:05-cv-12237-WGY
Document 1272-5
Filed 10/03/2007
Page 1 of 1
EXHIBIT 4
01/03/2007
Judge William G. Young : Electronic ORDER entered re 170 Motion to Compel. "Motion Denied as to Requests 20, 33-35, 58-59, 70, 105112. The Case Involves EPO, Including Pegylated EPO, Not Other Pegylated Compounds. In View of Amgen's Proffer as to Aranesp, The Motion is Otherwise Denied Without Prejudice to its Renewal Should That Discovery Not Be Sufficiently Comprehensive. The Documents Submitted by Amgen In Camera Shall Be Returned to it." (Paine, Matthew) (Entered: 01/03/2007)
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
